Aneurysmat

Aneurysmat is a rare vascular disorder characterized by the formation of ectatic, sac-like dilations within the arterial wall that are distinguished by the presence of an abnormal, fibrous membrane lining the lumen. The condition is most commonly observed in medium‐sized arteries of the cerebral and coronary circulations, but isolated cases have also been reported in peripheral vessels. The defining feature of aneurysmat is the development of a fibrotic layer that adheres to the endothelium, creating a distinctive “matrix” that may interfere with normal blood flow dynamics.

The exact etiology of aneurysmat remains unclear, although several hypotheses have been proposed. A strong genetic component has been suggested by familial clustering of cases; mutations in genes involved in extracellular matrix remodeling (such as COL3A1 and MMP9) have been implicated. Environmental factors, including chronic hypertension, smoking, and inflammatory conditions, appear to act synergistically with genetic predisposition to promote wall weakening and subsequent membrane formation. In addition, autoimmune mechanisms and chronic infections have been investigated as potential triggers.

Clinically, aneurysmats often present with the same symptoms as conventional aneurysms: pain, localized swelling, or neurologic deficits depending on the site. However, the fibrous membrane can lead to turbulent flow and an increased risk of thrombosis, which may alter symptomatology. Diagnosis is primarily achieved through imaging studies; high‐resolution magnetic resonance angiography (MRA) or computed tomography angiography (CTA) can reveal both the sac and the characteristic mural membrane. Histopathological confirmation remains the gold standard, demonstrating dense collagen deposition within the aneurysmal wall.

Management strategies mirror those used for standard aneurysms, with a focus on controlling blood pressure, antiplatelet therapy, and, when indicated, endovascular or surgical intervention. Endovascular coiling or flow‑diverting stents are preferred for intracranial cases, whereas open repair may be necessary for peripheral vessels with extensive membrane formation. Follow‑up imaging is essential to monitor for recurrence or progression. Research into the molecular pathways driving aneurysmat formation continues, with the aim of identifying targeted therapies that could prevent membrane development and reduce rupture risk.